Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Diadexus, Inc. (DDXS)
|
Add to portfolio |
|
|
|
| Price: |
$1.37
| | Metrics |
| OS: |
4.1
|
M
| |
|
|
| Market cap: |
$5.62
|
M
| |
-364
|
% ROIC
|
|
Net debt:
|
$7.02
|
M
| |
|
|
|
EV:
|
$12.6
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($5.7)
|
M
| |
|
|
|
EBIT
|
($6.0)
|
M
| |
|
|
| EPS |
($2.01)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 18.1 | 26.4 | 24.9 | 20.8 | 16.4 | 11.8 | 11.9 | 0.3 |
| Revenue growth | -31.4% | 6.2% | 19.8% | 26.8% | 39.4% | -1.5% | 3972.4% | -94.2% |
| Cost of goods sold | 5.4 | 7.4 | 7.2 | 6.3 | 5.4 | 4.7 | 3.5 | 0.0 |
| Gross profit | 12.8 | 19.1 | 17.7 | 14.5 | 11.0 | 7.1 | 8.5 | 0.3 |
| Gross margin | 70.4% | 72.1% | 71.0% | 69.7% | 67.0% | 60.4% | 71.1% | 100.0% |
| Sales and marketing | 4.9 | 10.1 | 7.5 | 5.5 | 4.1 | 5.1 | 6.7 | |
| Research and development | 4.3 | 6.3 | 4.7 | 4.2 | 5.1 | 4.9 | 3.7 | |
| General and administrative | 7.8 | 9.6 | 7.5 | 7.2 | 9.5 | 5.6 | 2.8 | 12.7 |
| EBIT | -5.3 | -7.0 | -2.0 | -2.4 | -7.8 | -8.6 | -4.7 | -25.6 |
| EBIT margin | -29.0% | -26.4% | -8.1% | -11.5% | -47.9% | -73.2% | -39.2% | -8751.5% |
| Pre-tax income | -7.2 | -8.5 | -2.2 | -2.8 | -7.5 | -8.7 | -5.3 | -12.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 |
| Tax rate | | | | | | 2.6% | 0.1% | 0.3% |
| Net income | -7.2 | -8.5 | -2.2 | -2.8 | -7.5 | -8.4 | -5.3 | -12.6 |
| Net margin | -39.6% | -32.0% | -8.7% | -13.4% | -45.7% | -71.9% | -44.3% | -4287.7% |
| |
| Diluted EPS | ($1.83) | ($2.30) | ($0.04) | ($0.05) | ($0.14) | ($0.25) | ($0.28) | ($0.38) |
| Shares outstanding (diluted) | 3.9 | 3.7 | 54.3 | 53.2 | 53.1 | 33.6 | 19.1 | 33.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|